The global turner syndrome drug market was valued at USD 2.75 billion in 2025 and is projected to reach USD 5.47 billion by 2035, rising at a CAGR of 7.1% during the forecast period. These headline figures reflect a combination of expanding diagnostic reach, wider access to specialty care, and steady uptake of hormone-based therapeutic regimens across pediatric and adult patient cohor... https://www.researchnester.com/reports/turner-syndrome-drug-market/2640